164 related articles for article (PubMed ID: 17204607)
1. Long-term follow-up of patients with non-Hodgkin lymphoma following myeloablative therapy and autologous transplantation of CD34+-selected peripheral blood progenitor cells.
Witzens-Harig M; Heilmann C; Hensel M; Kornacker M; Benner A; Haas R; Fruehauf S; Ho AD
Stem Cells; 2007 Jan; 25(1):228-35. PubMed ID: 17204607
[TBL] [Abstract][Full Text] [Related]
2. High-dose therapy with peripheral blood progenitor cell transplantation in low-grade non-Hodgkin's lymphoma.
Haas R; Moos M; Möhle R; Döhner H; Witt B; Goldschmidt H; Murea S; Flentje M; Wannenmacher M; Hunstein W
Bone Marrow Transplant; 1996 Feb; 17(2):149-55. PubMed ID: 8640159
[TBL] [Abstract][Full Text] [Related]
3. Factors affecting hemopoietic recovery after high-dose therapy and autologous peripheral blood progenitor cell transplantation: a single center experience.
Olivieri A; Offidani M; Montanari M; Ciniero L; Cantori I; Ombrosi L; Masia CM; Centurioni R; Mancini S; Brunori M; Leoni P
Haematologica; 1998 Apr; 83(4):329-37. PubMed ID: 9592983
[TBL] [Abstract][Full Text] [Related]
4. Collection of peripheral blood progenitor cells for autografting with low-dose cyclophosphamide plus granulocyte colony-stimulating factor.
Bellido M; Sureda A; Martino R; Madoz P; García J; Brunet S
Haematologica; 1998 May; 83(5):428-31. PubMed ID: 9658727
[TBL] [Abstract][Full Text] [Related]
5. High-dose therapy with peripheral blood progenitor cell support in patients with non-Hodgkin's lymphoma.
Haas R; Murea S; Goldschmidt H; Döhner H; Moos M; Witt B; Eugenhart R; Wannenmacher M; Hunstein W
Stem Cells; 1995 Dec; 13 Suppl 3():28-35. PubMed ID: 8747986
[TBL] [Abstract][Full Text] [Related]
6. [Autologous transplantation of hematopoietic precursor cells following CD34 selection].
Tichelli A; Gratwohl A; Bargetzi M; Nissen C; Wernli M; Herrmann R; Orth B; Signer E; Speck B
Schweiz Med Wochenschr; 1996 Feb; 126(6):201-6. PubMed ID: 8720723
[TBL] [Abstract][Full Text] [Related]
7. Autologous CD34+ cell transplantation for patients with advanced lymphoma: effects of overnight storage on peripheral blood progenitor cell enrichment and engraftment.
Koç ON; Gerson SL; Phillips GL; Cooper BW; Kutteh L; Van Zant G; Reece DE; Fox RM; Schupp JE; Tainer N; Lazarus HM
Bone Marrow Transplant; 1998 Feb; 21(4):337-43. PubMed ID: 9509966
[TBL] [Abstract][Full Text] [Related]
8. Myeloablative therapy with blood stem cell transplantation is effective in mantle cell lymphoma.
Haas R; Brittinger G; Meusers P; Murea S; Goldschmidt H; Wannenmacher M; Hunstein W
Leukemia; 1996 Dec; 10(12):1975-9. PubMed ID: 8946940
[TBL] [Abstract][Full Text] [Related]
9. Activity of interleukin-2 in non-Hodgkin's lymphoma following transplantation of interleukin-2-activated autologous bone marrow or stem cells.
van Besien K; Margolin K; Champlin R; Forman S
Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S54-8. PubMed ID: 9457395
[TBL] [Abstract][Full Text] [Related]
10. Isolation of CD34+ cells from blood stem cell components using the Baxter Isolex system.
Rowley SD; Loken M; Radich J; Kunkle LA; Mills BJ; Gooley T; Holmberg L; McSweeney P; Beach K; MacLeod B; Appelbaum F; Bensinger WI
Bone Marrow Transplant; 1998 Jun; 21(12):1253-62. PubMed ID: 9674860
[TBL] [Abstract][Full Text] [Related]
11. Autologous CD34-selected blood progenitor cell transplants for patients with advanced multiple myeloma.
Schiller G; Vescio R; Freytes C; Spitzer G; Lee M; Wu CH; Cao J; Lee JC; Lichtenstein A; Lill M; Berenson R; Berenson J
Bone Marrow Transplant; 1998 Jan; 21(2):141-5. PubMed ID: 9489630
[TBL] [Abstract][Full Text] [Related]
12. Autologous transplantation of mobilized peripheral blood CD34+ cells selected by immunomagnetic procedures in patients with multiple myeloma.
Abonour R; Scott KM; Kunkel LA; Robertson MJ; Hromas R; Graves V; Lazaridis EN; Cripe L; Gharpure V; Traycoff CM; Mills B; Srour EF; Cornetta K
Bone Marrow Transplant; 1998 Nov; 22(10):957-63. PubMed ID: 9849692
[TBL] [Abstract][Full Text] [Related]
13. Variables associated with the platelet count 6 weeks after autologous peripheral blood progenitor cell transplantation.
Bolwell B; Goormastic M; Andresen S; Koo A; Wise K; Overmoyer B; Pohlman B; Kalaycio M
Bone Marrow Transplant; 1998 Sep; 22(6):547-51. PubMed ID: 9758341
[TBL] [Abstract][Full Text] [Related]
14. High-dose cytotoxic therapy with autologous bone marrow or peripheral blood progenitor cell transplantation in malignant lymphomas.
Cucuianu A; D'Hondt L; Collignon J; Verhulst D; Deprijck B; Chatelain C; Doyen C; Bosly A
Rom J Intern Med; 1995; 33(3-4):211-25. PubMed ID: 8646194
[TBL] [Abstract][Full Text] [Related]
15. Alterations in both the hematopoietic microenvironment and the progenitor cell population follow the recovery from myeloablative therapy and bone marrow transplantation.
Novitzky N; Mohamed R
Exp Hematol; 1995 Dec; 23(14):1661-6. PubMed ID: 8542962
[TBL] [Abstract][Full Text] [Related]
16. Haematopoietic reconstitution after autologous transplantation of CD34(+)-selected versus non-selected peripheral blood progenitor cells.
Wiesneth M; Schreiner T; Sandherr M; Maccari B; Erne E; Bischof C; Frickhofen N; von Schilling C; Kubanek B
Beitr Infusionsther Transfusionsmed; 1997; 34():133-8. PubMed ID: 9356664
[TBL] [Abstract][Full Text] [Related]
17. Pediatric experience with autologous peripheral blood progenitor cell transplantation: influence of CD34+ cell dose in engraftment kinetics.
Diaz MA; Alegre A; Villa M; Granda A; de la Vega A; Ramirez M; Ruano D; Gonzalez A; Merino JM; Madero L
Bone Marrow Transplant; 1996 Oct; 18(4):699-703. PubMed ID: 8899183
[TBL] [Abstract][Full Text] [Related]
18. Progenitor cell yields are frequently poor in patients with histologically indolent lymphomas especially when mobilized within 6 months of previous chemotherapy.
Perry AR; Watts MJ; Peniket AJ; Goldstone AH; Linch DC
Bone Marrow Transplant; 1998 Jun; 21(12):1201-5. PubMed ID: 9674852
[TBL] [Abstract][Full Text] [Related]
19. [CD34-positive cell selection using an Isolex 300 system in patients with solid tumors and its application for autologous peripheral blood stem cell transplantation].
Kaneko H; Kimura T; Tsuda S; Ohkawara Y; Abe T; Sonoda Y
Rinsho Ketsueki; 1998 Sep; 39(9):652-7. PubMed ID: 9796398
[TBL] [Abstract][Full Text] [Related]
20. Long-term disease-free survival of patients with advanced mantle-cell lymphoma following high-dose chemotherapy.
Kröger N; Hoffknecht M; Dreger P; Krüger W; Zeller W; Krüll A; Stockschläder M; Bittner S; Weh HJ; Zander AR
Bone Marrow Transplant; 1998 Jan; 21(1):55-7. PubMed ID: 9486495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
